Engineered skeletal muscles for disease modeling and drug discovery.

TitleEngineered skeletal muscles for disease modeling and drug discovery.
Publication TypeJournal Article
Year of Publication2019
AuthorsJ Wang, A Khodabukus, L Rao, K Vandusen, N Abutaleb, and N Bursac
JournalBiomaterials
Volume221
Start Page119416
Date Published11/2019
Abstract

Skeletal muscle is the largest organ of human body with several important roles in everyday movement and metabolic homeostasis. The limited ability of small animal models of muscle disease to accurately predict drug efficacy and toxicity in humans has prompted the development in vitro models of human skeletal muscle that fatefully recapitulate cell and tissue level functions and drug responses. We first review methods for development of three-dimensional engineered muscle tissues and organ-on-a-chip microphysiological systems and discuss their potential utility in drug discovery research and development of new regenerative therapies. Furthermore, we describe strategies to increase the functional maturation of engineered muscle, and motivate the importance of incorporating multiple tissue types on the same chip to model organ cross-talk and generate more predictive drug development platforms. Finally, we review the ability of available in vitro systems to model diseases such as type II diabetes, Duchenne muscular dystrophy, Pompe disease, and dysferlinopathy.

DOI10.1016/j.biomaterials.2019.119416
Short TitleBiomaterials